Search

Your search keyword '"Morré, S. A."' showing total 262 results
Start Over Author "Morré, S. A."
262 results on '"Morré, S. A."'

21. Corrigendum. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study (vol 33, pg 2002-2009, 2018, 33)

Author

Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., and Laven, J. S.E.

Subjects
Journal Article
Abstract

The authors of the above article would like to apologise for errors in Figure 3 of their article. An old version of the figure file image was uploaded by the authors, with sub-sections A, B, C and D rearranged. The correct version of Figure 3 is included overpage. The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dez065. The authors would liketo assure readers that this does not affect any content of the article. (Figure Presented).

Published
2019

22. Corrigendum:The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: A prospective study (Human Reproduction (2018) 33 (2002-2009) DOI: 10.1093/humrep/dez065)

Author

Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H. M., Morré, S. A., de Jonge, J. D., Poort, L., Cuypers, W. J. S. S., Beckers, N. G. M., Broekmans, F. J. M., Cohlen, B. J., den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M. J. S., Budding, A. E., and Laven, J. S. E.

Abstract

The authors of the above article would like to apologise for errors in Figure 3 of their article. An old version of the figure file image was uploaded by the authors, with sub-sections A, B, C and D rearranged. The correct version of Figure 3 is included overpage. The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dez065. The authors would liketo assure readers that this does not affect any content of the article. (Figure Presented).

Published
2019
Full Text
View/download PDF

39. The Y-chromosome F haplogroup contributes to the development of Barrett’s esophagus-associated esophageal adenocarcinoma in a white male population

Author

Westra, W M, primary, Rygiel, A M, additional, Mostafavi, N, additional, de Wit, G M J, additional, Roes, A L, additional, Moons, L M G, additional, Peppelenbosch, M P, additional, Ouburg, S, additional, Morré, S A, additional, Jacobs, M, additional, Siersema, P D, additional, Repping, S, additional, Wang, K K, additional, and Krishnadath, K K, additional

Published
2020
Full Text
View/download PDF

40. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study

Author

Koedooder, R, primary, Singer, M, additional, Schoenmakers, S, additional, Savelkoul, P H M, additional, Morré, S A, additional, de Jonge, J D, additional, Poort, L, additional, Cuypers, W J S S, additional, Beckers, N G M, additional, Broekmans, F J M, additional, Cohlen, B J, additional, den Hartog, J E, additional, Fleischer, K, additional, Lambalk, C B, additional, Smeenk, J M J S, additional, Budding, A E, additional, and Laven, J S E, additional

Published
2019
Full Text
View/download PDF

41. Corrigendum. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study (vol 33, pg 2002-2009, 2018, 33)

Author

MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., Laven, J. S.E., MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., and Laven, J. S.E.

Published
2019

42. The Vaginal Microbiome as a Predictor for Outcome of In Vitro Fertilization With or Without Intracytoplasmic Sperm Injection: A Prospective Study

Author

MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., Laven, J. S.E., MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., and Laven, J. S.E.

Published
2019

43. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: A prospective study

Author

AIOS Anesthesiologie, UMC Utrecht, MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., Laven, J. S.E., AIOS Anesthesiologie, UMC Utrecht, MS VPG/Gynaecologie, Child Health, Circulatory Health, Koedooder, R., Singer, M., Schoenmakers, S., Savelkoul, P. H.M., Morré, S. A., De Jonge, J. D., Poort, L., Cuypers, W. J.S.S., Beckers, N. G.M., Broekmans, F. J.M., Cohlen, B. J., Den Hartog, J. E., Fleischer, K., Lambalk, C. B., Smeenk, J. M.J.S., Budding, A. E., and Laven, J. S.E.

Published
2019

44. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

Author

Hoenderboom, B. M., primary, van Oeffelen, A. A. M., additional, van Benthem, B. H. B., additional, van Bergen, J. E. A. M., additional, Dukers-Muijrers, N. H. T. M., additional, Götz, H. M., additional, Hoebe, C. J. P. A., additional, Hogewoning, A. A., additional, van der Klis, F. R. M., additional, van Baarle, D., additional, Land, J. A., additional, van der Sande, M. A. B., additional, van Veen, M. G., additional, de Vries, F., additional, Morré, S. A., additional, and van den Broek, I. V. F., additional

Published
2017
Full Text
View/download PDF

45. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

Author

Hoenderboom, B M, van Oeffelen, A A M, van Benthem, B H B, van Bergen, J E A M, Dukers-Muijrers, N H T M, Götz, H M, Hoebe, C J P A, Hogewoning, A A, van der Klis, F R M, van Baarle, D, Land, J.A., van der Sande, M A B, Van Veen, M.G., de Vries, F, Morré, S A, van den Broek, I V F, Hoenderboom, B M, van Oeffelen, A A M, van Benthem, B H B, van Bergen, J E A M, Dukers-Muijrers, N H T M, Götz, H M, Hoebe, C J P A, Hogewoning, A A, van der Klis, F R M, van Baarle, D, Land, J.A., van der Sande, M A B, Van Veen, M.G., de Vries, F, Morré, S A, and van den Broek, I V F

Abstract

BACKGROUND: Chlamydia trachomatis (CT), the most common bacterial sexually transmitted infection (STI) among young women, can result in serious sequelae. Although the course of infection is often asymptomatic, CT may cause pelvic inflammatory disease (PID), leading to severe complications, such as prolonged time to pregnancy, ectopic pregnancy, and tubal factor subfertility. The risk of and risk factors for complications following CT-infection have not been assessed in a long-term prospective cohort study, the preferred design to define infections and complications adequately.METHODS: In the Netherlands Chlamydia Cohort Study (NECCST), a cohort of women of reproductive age with and without a history of CT-infection is followed over a minimum of ten years to investigate (CT-related) reproductive tract complications. This study is a follow-up of the Chlamydia Screening Implementation (CSI) study, executed between 2008 and 2011 in the Netherlands. For NECCST, female CSI participants who consented to be approached for follow-up studies (n = 14,685) are invited, and prospectively followed until 2022. Four data collection moments are foreseen every two consecutive years. Questionnaire data and blood samples for CT-Immunoglobulin G (IgG) measurement are obtained as well as host DNA to determine specific genetic biomarkers related to susceptibility and severity of infection. CT-history will be based on CSI test outcomes, self-reported infections and CT-IgG presence. Information on (time to) pregnancies and the potential long-term complications (i.e. PID, ectopic pregnancy and (tubal factor) subfertility), will be acquired by questionnaires. Reported subfertility will be verified in medical registers. Occurrence of these late complications and prolonged time to pregnancy, as a proxy for reduced fertility due to a previous CT-infection, or other risk factors, will be investigated using longitudinal statistical procedures.DISCUSSION: In the proposed study, the

Published
2017

46. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

Author

Hoenderboom, B. M., van Oeffelen, A. A.M., van Benthem, B. H.B., van Bergen, J. E.A.M., Dukers-Muijrers, N. H.T.M., Götz, H. M., Hoebe, C. J.P.A., Hogewoning, A. A., van der Klis, F. R.M., van Baarle, D., Land, J. A., van der Sande, M. A.B., van Veen, M. G., de Vries, F., Morré, S. A., van den Broek, I. V.F., Hoenderboom, B. M., van Oeffelen, A. A.M., van Benthem, B. H.B., van Bergen, J. E.A.M., Dukers-Muijrers, N. H.T.M., Götz, H. M., Hoebe, C. J.P.A., Hogewoning, A. A., van der Klis, F. R.M., van Baarle, D., Land, J. A., van der Sande, M. A.B., van Veen, M. G., de Vries, F., Morré, S. A., and van den Broek, I. V.F.

Published
2017

47. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

Author

Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Hoenderboom, B M, van Oeffelen, A A M, van Benthem, B H B, van Bergen, J E A M, Dukers-Muijrers, N H T M, Götz, H M, Hoebe, C J P A, Hogewoning, A A, van der Klis, F R M, van Baarle, D, Land, J.A., van der Sande, M A B, Van Veen, M.G., de Vries, F, Morré, S A, van den Broek, I V F, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Hoenderboom, B M, van Oeffelen, A A M, van Benthem, B H B, van Bergen, J E A M, Dukers-Muijrers, N H T M, Götz, H M, Hoebe, C J P A, Hogewoning, A A, van der Klis, F R M, van Baarle, D, Land, J.A., van der Sande, M A B, Van Veen, M.G., de Vries, F, Morré, S A, and van den Broek, I V F

Published
2017

48. The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women

Author

Cardiovasculaire Epi Team 5, CTI Borghans, Epi Infectieziekten Team 1, Infection & Immunity, JC onderzoeksprogramma Infectieziekten, Hoenderboom, B. M., van Oeffelen, A. A.M., van Benthem, B. H.B., van Bergen, J. E.A.M., Dukers-Muijrers, N. H.T.M., Götz, H. M., Hoebe, C. J.P.A., Hogewoning, A. A., van der Klis, F. R.M., van Baarle, D., Land, J. A., van der Sande, M. A.B., van Veen, M. G., de Vries, F., Morré, S. A., van den Broek, I. V.F., Cardiovasculaire Epi Team 5, CTI Borghans, Epi Infectieziekten Team 1, Infection & Immunity, JC onderzoeksprogramma Infectieziekten, Hoenderboom, B. M., van Oeffelen, A. A.M., van Benthem, B. H.B., van Bergen, J. E.A.M., Dukers-Muijrers, N. H.T.M., Götz, H. M., Hoebe, C. J.P.A., Hogewoning, A. A., van der Klis, F. R.M., van Baarle, D., Land, J. A., van der Sande, M. A.B., van Veen, M. G., de Vries, F., Morré, S. A., and van den Broek, I. V.F.

Published
2017

49. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study

Author

Alberts, C J, primary, Vos, R A, additional, Borgdorff, H, additional, Vermeulen, W, additional, van Bergen, J, additional, Bruisten, S M, additional, Geerlings, S E, additional, Snijder, M B, additional, van Houdt, R, additional, Morré, S A, additional, de Vries, H J C, additional, van de Wijgert, J H H M, additional, Prins, M, additional, and Schim van der Loeff, M F, additional

Published
2016
Full Text
View/download PDF

50. NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report

Author

Barreiro-de Acosta, M., Ouburg, S., Morré, S. A., Crusius, J. B. A., Lorenzo, A., Potel, J., Peña, A. S., and Domínguez-Muñoz, J. E.

Subjects
Crohn's disease, Genotypes, Adalimumab
Abstract

Introduction: adalimumab is a recombinant fully-human monoclonal immunoglobulin (IgG1) antibody utilized in the treatment of Crohn's disease. Unfortunately no clinical or genetic markers exist to predict response to anti-tumor necrosis factor-alpha (TNF) therapy. The aim of this study was to evaluate the association between selected genes involved in cytokine regulation and response to adalimumab treatment in Crohn's disease. Methods: twenty-four patients with Crohn's disease either naïve (n = 8) or had lost response or were unable to tolerate the chimeric anti-TNF antibody infliximab (n=16) were enrolled in the study. Patients were genotyped for main polymorphisms in NOD2, CD14 and TLR4 genes. Response to adalimumab treatment was defined as a decrease of Crohn's disease activity index of at least 100 points or a closure of at least 50% of fistulas in case of fistulizing Crohn's disease. Results: overall, 75% of patients did respond to treatment. However, no statistically significant association was found between any of the genotypes and the response to adalimumab. Conclusions: in our small study group no association between the studied polymorphisms and response to adalimumab was apparent. Systematic studies to search for genetic markers of response to anti-TNF therapy are necessary.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results